The change of miR-146a in carcinoma tissues and peripheral blood of patients with papillary thyroid carcinoma
10.3760/cma.j.issn.1674-6090.2013.01.021
- VernacularTitle:甲状腺乳头状癌组织及外周血中miR-146a含量变化
- Author:
Qingxia CHI
;
Yangang WANG
;
Wenjuan ZHAO
;
Xiaolong YU
;
Ping WANG
;
Xin LIU
;
Shihua ZHAO
- Publication Type:Journal Article
- Keywords:
Papillary thyroid carcinoma;
miRNA;
miR-146a;
Polymerase chain reaction
- From:
Journal of Endocrine Surgery
2013;7(1):56-59
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the change of miR-146a in the development and progression of papillary thyroid carcinoma(PTC).Methods Real-time fluorescence quantitative polymerase chain reaction was used to detect the change of miR-146a in tumor tissues of 43 cases of PTC and 36 cases of nodular goiter,also in peripheral blood of 32 cases of PTC and 23 cases of nodular goiter.The correlation of miR-146a change and the clinicopathological parameters of patients with PTC was analyzed.Results ① The relative content of miR-146a in the 43 patients with PTC and 36 patients with nodular goiter was 0.0280 ± 0.0131 and 0.0212 ± 0.0111 respectively.The difference had statistical significance (P ＜ 0.05).miR-146a in PTC tissues was significantly correlated to clinicopathological parameters such as lymph node metastasis,tumor stage (P ＜ 0.05),and it was unrelated to age or tumor size(P ＞0.05).② The relative content of miR-146a in peripheral blood of 32 patients with PTC and 23 patients with nodular goiter was 0.0891 ±0.0419 and 0.0922 ±0.0456 respectively.The difference had no statistical significance(P ＞ 0.05).There was no significant correlation between miR-146a in peripheral blood of patients with PTC and age,tumor stage,lymph node metastasis,or tumor size of patients (P ＞ 0.05).Conclusions MiR-146a expression is upregulated in patients with PTC,and there is a significant correlation between miR-146a content and clinicopathological parameters such as lymph node metastasis,tumor stage,especially in advanced stage.It suggests that miR-146a may play a role in carcinogenesis and development of PTC.
